| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.29 | 4e-07 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.26 | 4e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.21 | 7e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0007 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |